Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Chinese authorities investigate AstraZeneca for data privacy violations and unlicensed medication imports.

flag AstraZeneca's CEO, Pascal Soriot, announced that Chinese authorities are investigating allegations of illegal activities involving a few current and former employees, including data privacy violations and unlicensed medication imports. flag The company maintains compliance with Chinese regulations and is cooperating with the investigation. flag Additionally, AstraZeneca reported findings from a lung cancer drug trial, showing a two-month survival improvement, though results lacked statistical significance.

10 Articles